Heron Bay Capital Management Regeneron Pharmaceuticals, Inc. Transaction History

Heron Bay Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 12, 2023	BUY	$700.03 - $830.35 $7,700 - $9,133	11 Added 1.08%	1,034 $742,000
Q1 2023 May 11, 2023	BUY	$680.49 - $826.97 $696,141 - $845,990	1,023 New	1,023 $840,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $2.19 Million - $2.57 Million	-3,686 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $22,826 - $28,180	42 Added 1.15%	3,686 $2.33 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $548,198 - $650,316	955 Added 35.52%	3,644 $2.21 Million
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $27,895 - $32,953	59 Added 2.24%	2,689 $1.5 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $207,282 - $254,364	464 Added 21.42%	2,630 $1.24 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $1.04 Million - $1.32 Million	2,166 New	2,166 $1.05 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Heron Bay Capital Management, based on Form 13F filings with the SEC.

Stay updated on Heron Bay Capital Management with notifications on news.